Site Assessment and Audits
Aepodia is experienced in the evaluation of Phase I units, hospital-based investigational sites and different vendors involved in clinical trials.
Our evaluations are performed by qualified auditors in accordance with EMEA INS-GCP-3 Annex 3 and MHRA Accreditation standards and country specific regulations.
Aepodia auditors evaluate Phase 1 trial related vendors in accordance with relevant GCP, GMP, GLP and Computer System Validation requirements.
Audit reports are shared with clients as well as any corrective action plans and follow up.
